Laua, Y. Et Al. 2022. Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study. VACCINE , vol.40, no.14 .

Laua, Y., Leungb, T., Çetin, B. Ş., Dinleyici, E. Ç., Huange, L., Halperin, S. A., ... Hsiaog, C.(2022). Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study. VACCINE , vol.40, no.14.

Laua, Yu-Lung Et Al. "Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study," VACCINE , vol.40, no.14, 2022

Laua, Yu-Lung Et Al. "Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study." VACCINE , vol.40, no.14, 2022

Laua, Y. Et Al. (2022) . "Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study." VACCINE , vol.40, no.14.

@article{article, author={Yu-Lung Laua Et Al. }, title={Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study}, journal={VACCINE}, year=2022}